Gudula J.A.M. Boon
- Internal Medicine top 1%
- Venous Thromboembolism Diagnosis and Management 16
-
- Ultrasound in Clinical Applications 3
- Neurology top 5%
-
- Atrial Fibrillation Management and Outcomes 5
- Cardiac tumors and thrombi 2
- Heart Rate Variability and Autonomic Control 1
- Clinical Psychology top 10%
-
- Pulmonary Hypertension Research and Treatments 13
-
- Acute Ischemic Stroke Management 2
-
- Diagnosis and Treatment of Venous Diseases 2
Gudula J.A.M. Boon
20 papers receiving 778 citations
Hit Papers
Peers
Comparison fields: 5 of 66
- Internal Medicine 306
- Critical Care and Intensive Care Medicine 190
- Neurology 361
- Cardiology and Cardiovascular Medicine 204
- Clinical Psychology 176
Countries citing papers authored by Gudula J.A.M. Boon
This map shows the geographic impact of Gudula J.A.M. Boon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gudula J.A.M. Boon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gudula J.A.M. Boon more than expected).
Fields of papers citing papers by Gudula J.A.M. Boon
This network shows the impact of papers produced by Gudula J.A.M. Boon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gudula J.A.M. Boon. The network helps show where Gudula J.A.M. Boon may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gudula J.A.M. Boon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 9 | |
| 2 | 2023 | 3 | |
| 3 | 2022 | 3 | |
| 4 | 2021 | 13 | |
| 5 | 2021 | 18 | |
| 6 | 2021 | 39 | |
| 7 | 2021 | 19 | |
| 8 | 2021 | 30 | |
| 9 | 2021 | 26 | |
| 10 | 2021 | 28 | |
| 11 | The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19breakdown → | 2020 | 394 |
| 12 | 2020 | 30 | |
| 13 | 2020 | 5 | |
| 14 | 2020 | 7 | |
| 15 | 2020 | 48 | |
| 16 | 2020 | 10 | |
| 17 | 2019 | 53 | |
| 18 | 2018 | 22 | |
| 19 | 2015 | 45 | |
| 20 | [Value of biochemistry performed in pre-hospital cardiology]. | 2005 | 2 |
About Gudula J.A.M. Boon
Gudula J.A.M. Boon is a scholar working on Internal Medicine, Critical Care and Intensive Care Medicine and Cardiology and Cardiovascular Medicine, having authored 20 papers that have together received 804 indexed citations. Recurring topics across this work include Venous Thromboembolism Diagnosis and Management (16 papers), Pulmonary Hypertension Research and Treatments (13 papers), Atrial Fibrillation Management and Outcomes (5 papers), Ultrasound in Clinical Applications (3 papers), Acute Ischemic Stroke Management (2 papers), Cardiac tumors and thrombi (2 papers), Diagnosis and Treatment of Venous Diseases (2 papers) and Heart Rate Variability and Autonomic Control (1 paper). The work is most often cited by research in Internal Medicine (306 citations), Critical Care and Intensive Care Medicine (190 citations) and Neurology (361 citations). Gudula J.A.M. Boon has collaborated with scholars based in Netherlands, Belgium and Switzerland. Frequent co-authors include Frederikus A. Klok, Stefano Barco, Bob Siegerink, Martijn A. Spruit, J.J. Miranda Geelhoed, Matthias Endres, Spencer Rezek, Jörg Janne Vehreschild, Samuel Knauß and Menno V. Huisman.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.